Nissan Chemical extends supply agreement with MSD Animal Health for Fluralaner

Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,

Hikal appoints Dr. Raghavendar Morthala as Head – CDMO R&T Pharma & Animal Health BU

USDA approves Merck Animal Health’s NOBIVAC NXT canine flu H3N2

Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease

Blacksmith Medicines and Zoetis collaborate for novel animal health antibiotics

Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock

Merck Animal Health to acquire Elanco’s aqua business

Bolsters Merck Animal Health’s position in the aqua industry with comprehensive approach to ensure fish health, welfare and sustainability in aquaculture, conservation and fisheries

Merck Animal Health receives positive CVMP opinion for an injectable formulation of Bravecto

The CVMP recommends the product for approval for the treatment and persistent killing of fleas

Boehringer Ingelheim and the World Association for Buiatrics support research on ruminant animal health

Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now

Argenta acquires Klifovet to expand global footprint in animal health

Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups

Cadila Healthcare completes sale of animal healthcare business

The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.

Cadila Healthcare divests animal health business: ICICI Securities

The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.